Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents
Authors:
- Cindy L. GrinesCGCindy L. Grines
- Robert O. BonowRBRobert O. Bonow
- Donald E. CaseyDCDonald E. Casey
- Timothy J. GardnerTGTimothy J. Gardner
- Peter B. LockhartPLPeter B. Lockhart
- David J. MoliternoDMDavid J. Moliterno
- Patrick O'GaraPOPatrick O'Gara
- Patrick WhitlowPWPatrick Whitlow
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- Bleeding and management of bleedingEuropean Heart Journal Supplements, 2006
- Relationship between aspirin use and postoperative bleeding from dental extractions in a healthy populationOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Frequency of and Risk Factors for Stent Thrombosis After Drug-Eluting Stent Implantation During Long-Term Follow-UpThe American Journal of Cardiology, 2006
- Pathology of Drug-Eluting Stents in HumansJACC, 2006
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical PracticeCirculation, 2006
- Major noncardiac surgery following coronary stenting: When is it safe to operate?Catheterization and Cardiovascular Interventions, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugsBritish Dental Journal, 2003